Brief: X4 Pharmaceuticals Q3 EPS USD -0.18 Vs. IBES Estimate USD -0.17
13/11/2024 11:07
Nov 13 (Reuters) - X4 Pharmaceuticals Q3 income from operations USD -34.5 million. * Q3 net income USD -36.696 million * Q3 operating expenses USD 35.06 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule